Informação sobre produto
Ledipasvir D-tartrate is a synthetic, broad-spectrum antiviral agent that is used to treat hepatitis C virus (HCV) infection. It inhibits the HCV NS5A protein, which is needed for viral replication and assembly. Ledipasvir D-tartrate was discovered by scientists at Gilead Sciences. The drug was approved for use in combination with sofosbuvir in 2017 as an oral treatment for chronic HCV infection.
Ledipasvir D-tartrate binds to the NS5A protein and blocks its ability to function, thereby inhibiting viral replication. Ledipasvir D-tartrate also prevents the production of new viruses by blocking the activity of other proteins needed for viral assembly and release from infected cells.
It is effective against a wide variety of microorganisms, including bacteria, fungi, and parasites. It has been shown to be active against methicillin-resistant Staphylococ
Propriedades químicas
Consulta técnica sobre: 3D-FL180961 Ledipasvir D-tartrate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
